News tagged ‘BreastCancer’ clear
- Although some breast cancer activists are losing patience that a cure has not been found, Dr. Ann Partridge says there have been many advances in breast cancer research and care, including the identification of several breast cancer subtypes, which require treatments to be tailor to each patient.
- Dr. Andrea Richardson and colleagues have identified a genetic marker that may predict which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies.
Tags: BreastCancer, Genomics, OvarianCancer, GynecologicCancers
- Breast cancer surgeons have been having an ongoing discussion on how much tissue to breast tissue to remove when removing a tumor. Dr. Mehra Golshan said that with ductal carcinoma in situ (DCIS), a very treatable, early stage cancer, smaller margins are acceptable and appropriate.
Tags: BreastCancer, Surgery
- Children diagnosed with cancer remain at risk from a variety of serious, long-term complications. Dr. Lisa Diller from Dana-Farber/Children's Hospital Cancer Center says that new treatments can mitigate these risks for the next generation of pediatric cancer survivors.
Tags: BreastCancer, ChildhoodCancer, Survivorship
- A recent study found that for every 2,500 women offered mammograms over ten years, one breast-cancer death was averted, but six to ten women were subjected to unnecessary surgery, radiation and/or chemotherapy. Dr. Eric Winer of Dana-Farber said that while there are patients who are overtreated, there also are 40,000 women every year who die of breast cancer. (Full article requires a subscription)
- Dana-Farber researchers were part of The Cancer Genome Atlas study that identified four genetically distinct types of breast cancer, each with its own biology and survival outlooks. Matthew Meyerson, MD, PhD, one of the study's co-authors, said the findings could help direct the development of better treatments, adding that it likely will result in new combination therapies rather than one "silver bullet" drug.
Tags: BreastCancer, Genomics
- Judy Garber, MD, MPH, discussed the potential clinical implications of the findings from a study from The Cancer Genome Atlas that identified four genetically distinct types of breast cancer.
Tags: BreastCancer, Genomics
- A study led by Dr. Richard Gelber found that treating HER-2 positive breast cancer for one year with trastuzumab remains the standard of care. Researchers compared outcomes of the standard one-year course to a two-year treatment and a six-month treatment, and determined the one-year course was most beneficial.
- Although breast cancer is rare in young women, research shows that the risk of developing breast cancer increases in the five years or so after giving birth. Dr. Eric Winer from Dana-Farber says pregnancy hormones may spur the growth of pre-existing cancer cells, causing a woman to be diagnosed with breast cancer sooner than she might have been had she not been pregnant.